By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo ...

Cigna (CI) is ending coverage for GLP-1 weight-loss drugs such as Eli Lilly's (LLY) Zepbound and Novo Nordisk’s (NVO) Wegovy ...

Starting July 2026, Cigna is drawing a line in the sand by discontinuing coverage for popular weight-loss medications like ...

Sheridan Capital Partners ("Sheridan") today announced the completion of its investment in Tres Health, Inc. ("Tres" or the ...

Explore US health insurance stocks, key managed care risks, Medicare Advantage pressure, and major healthcare names shaping ...

Lexington Health, one of the Midlands' largest healthcare providers, is pursuing multiple expansion and partnership ...

ACA subsidies and Medicaid expansion are on the chopping block. Here's what your options are if you're about to lose coverage.

Arizona Attorney General Kris Mayes has filed a lawsuit accusing several major health insurance companies of conspiring to ...

Arizona Attorney General Kris Mayes filed a lawsuit against MultiPlan and eight major insurers for allegedly using a shared ...

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...

Attorney General Kris Mayes said some major insurance companies are violating the consumer fraud and antitrust laws in ...

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...